Testing the ARCHITECT applicator in cervical cancer radiation treatment
Tests a custom-fitted device for delivering internal radiation to locally advanced cervical cancer in adults.
Plain-language title generated from the registry record
Registry title: Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
Key facts
- Where
- Rotterdam, NetherlandsSee the site
Where in Netherlands
- Erasmus Medical CenterRotterdam, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Erasmus Medical Center
- Trial code
- NCT07435987
- Record updated
- 25 September 2026
- Original description
This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.Read full original descriptionShow less
Clinical Feasibility of the ARCHITECT Applicator in High-dose-rate Cervical Cancer Brachytherapy
This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.
Inclusion: Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy; Written informed consent.
Exclusion: Known nylon allergy; Unable to give informed consent; Tumour extension in the lower 2/3rd of the vagina; Requiring a Geneva tandem with ovoids' size 13 mm in the first application for brachytherapy.